Derived from soil bacteria on Easter Island, rapamycin is an immunosuppressant and anti-aging compound. It blocks a key cellular pathway (mTOR) to prevent organ rejection in transplant patients and is studied for extending healthspan. Benefits include transplant recipients, cancer patients, and aging adults exploring longevity therapies.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends